Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0001193125-26-014117

Director acquired 5,406 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Jerman Michael Allen Director 2026-01-12 Grant or award +5,406 $2.89 $15,623 9,589 D
Loading xslF345X05/ownership.xml…